# Ultragenyx Pharmaceutical Inc. (RARE) — Shareholder Equity

## Annual Shareholder Equity (USD)

| Year | Shareholder Equity |
| --- | --- |
| 2025 | -$80M |
| 2024 | $255M |
| 2023 | $275M |
| 2022 | $352M |
| 2021 | $923M |
| 2020 | $1.15B |
| 2019 | $654M |
| 2018 | $609M |
| 2017 | $383M |
| 2016 | $474M |

Source: [MarketCapTrends](https://marketcaptrends.com/company/RARE/shareholders-equity)